Our drug development pipeline

At Amylon, we are developing medicines for patients with serious unmet medical need. Our pipeline consists of carefully selected candidate ASO-therapies that target genetic diseases in the central nervous system. These candidate therapies have the potential to transform the lives of patients and their families.